HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Development of quantitative molecular clinical end points for siRNA clinical trials.

Abstract
RNA interference (RNAi) is an evolutionarily conserved mechanism that results in specific gene inhibition at the mRNA level. The discovery that short interfering RNAs (siRNAs) are selective, potent, and can largely avoid immune surveillance has resulted in keen interest to develop these inhibitors as therapeutics. A single nucleotide-specific siRNA (K6a_513a.12, also known as TD101) was recently evaluated in a phase 1b clinical trial for the rare skin disorder, pachyonychia congenita (PC). To develop a clinical trial molecular end point for this type of trial, methods were developed to: (1) isolate total RNA containing amplifiable mRNA from human skin and callus material; (2) quantitatively distinguish the single-nucleotide mutant mRNA from wild-type K6a mRNA in both patient-derived keratinocytes and patient callus; and (3) demonstrate that repeated siRNA treatment results in sustained inhibition of mutant K6a mRNA in patient-derived keratinocyte cultures. These methods allow noninvasive sampling and monitoring of gene expression from patient-collected shavings and may be useful in evaluating the effectiveness of RNAi-based therapeutics, including inhibitors that specifically target single-nucleotide mutations.
AuthorsRobyn P Hickerson, Sancy A Leachman, Lana N Pho, Emilio Gonzalez-Gonzalez, Frances J D Smith, W H Irwin McLean, Christopher H Contag, Devin Leake, Leonard M Milstone, Roger L Kaspar
JournalThe Journal of investigative dermatology (J Invest Dermatol) Vol. 131 Issue 5 Pg. 1029-36 (May 2011) ISSN: 1523-1747 [Electronic] United States
PMID21191405 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Keratin-6
  • RNA, Messenger
  • RNA, Small Interfering
Topics
  • Bony Callus (chemistry)
  • Cells, Cultured
  • Clinical Trials as Topic
  • Humans
  • Keratin-6 (genetics)
  • Keratinocytes (chemistry)
  • Pachyonychia Congenita (therapy)
  • Polymorphism, Single Nucleotide (genetics)
  • RNA Interference
  • RNA, Messenger (isolation & purification)
  • RNA, Small Interfering (genetics, therapeutic use)
  • Skin (chemistry)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: